ASNC expressed frustration with the HOPPS final rule’s reassignment of CPT code 78803, which will result in a 57% reimbursement reduction for PYP/amyloid imaging. Despite ASNC's advocacy efforts, CMS did not halt or delay the code's reassignment. The final rule will take effect Jan. 1, 2026. View ASNC’s analysis of the HOPPS final rule, and watch for news about ASNC’s upcoming webinar focused on payment changes, including how hospital cost reporting can impact reimbursement.

Catalyst delivers immediate access to advanced cardiology imaging systems. Our ready-to-deploy OEM Digirad portfolio is built for where the field is headed.

Learn More

A study presented at a Radiological Society of North America conference found long-term exposure to air pollution was associated with more advanced obstructive coronary artery disease on cardiac CT imaging. "The results of this study add to the growing body of evidence that air pollution is a modifiable cardiovascular risk factor and reinforce the need for further research to understand why these associations differ between men and women," said researcher Dr. Kate Hanneman.

A study published in The Lancet found semaglutide improved cardiovascular outcomes for patients with overweight or obesity but without diabetes, regardless of their baseline adiposity. The analysis of data from the SELECT trial demonstrated a reduction in major adverse cardiovascular events across various BMI groups.

A Concise Clinical Guidance report from the American College of Cardiology supports the FDA's proposal to require front-of-package nutrition labeling on food products, citing the potential to improve diet quality, reduce cardiovascular disease risk and advance equity in public health. The FDA proposal would require manufacturers to add boxes to the front of packages showing levels of sodium, added sugar and saturated fat, according to the clinical guidance in the Journal of the American College of Cardiology.

US Reps. John Joyce, R-Pa., and Scott Peters, D-Calif., have introduced the Health Tech Investment Act, which aims to improve access to AI-enabled medical devices by ensuring payment for innovative technologies. It would give all FDA-approved AI devices a new classification in the hospital outpatient payment system.

The FDA has introduced the Technology-Enabled Meaningful Patient Outcomes pilot program to accelerate the market entry of digital health technologies for chronic diseases. The program will work within the CMS' Advancing Chronic Care with Effective, Scalable Solutions model to improve access to health technologies for conditions such as high blood pressure, diabetes, chronic pain and depression. Up to 10 device manufacturers in four clinical areas will be selected to participate in the initiative, which will collect real-world performance data.